| These headings link you to the corresponding sections below |
Click  Show Links to expand a section or sub-section |
|
  |
|
Clinic Resources and Tools |
|
|
|
 |
 |
Vaccine administration |
|
|
Clinical considerations for use
of COVID-19 vaccines |
|
|
Clinical care considerations |
|
|
Vaccine safety |
|
|
Vaccine storage and handling (includes temperature logs) |
|
|
Training materials for providers |
|
|
Administrative and operational
issues |
|
 |
|
Information about COVID-19 Vaccine Products |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pfizer-BioNTech COVID-19 vaccine (mRNA)
 All formulations
Show Links |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Moderna COVID-19 vaccine (mRNA)
 All formulations
Show Links |
|
|
|
|
|
|
|
|
|
|
|
|
|
Janssen COVID-19 Vaccine (Johnson & Johnson) (viral vector)
Show Links |
|
|
|
|
|
|
|
|
|
|
|
|
Vaccine Fact Sheets (EUA, FDA-Licensed, and EUI) |
|
|
Fact Sheets for Pfizer-BioNTech COVID-19 Vaccines
 Age 6 months through 4 years (maroon cap)
Show Links |
|
|
|
|
|
|
|
|
|
|
|
|
Fact Sheets for Pfizer-BioNTech COVID-19 Vaccines
 Age 5 through 11 years (orange cap)
Show Links |
|
|
|
|
|
|
|
|
|
|
|
|
|
Fact Sheets for Pfizer-BioNTech COVID-19 Vaccines
 Age 12 years and older – dilute before use (purple cap)
Show Links |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Emergency Use Instructions (EUI) |
|
|
|
|
|
|
|
Fact Sheets for Pfizer-BioNTech COVID-19 Vaccines
 Age 12 years and older – do not dilute (gray cap)
Show Links |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Emergency Use Instructions (EUI) |
|
|
|
|
|
|
|
Fact Sheets for Moderna COVID-19 Vaccines
 Age 6 months through 5 years (dark blue cap, magenta [pink] border)
Show Links |
|
|
|
|
|
|
|
|
|
|
|
|
Fact Sheets for Moderna COVID-19 Vaccines
 Age 6 through 11 years for primary series and age 18+ for 0.5 mL booster dose
(dark blue cap, purple border)
This single formulation has separate EUA fact sheets for its use as a primary series dose in children age 6 through 11 years and for its use as a booster dose in adults 18+. The EUA fact sheets for age 6 through 11 years also reference packaging with a dark blue cap and teal border that is not yet available in the U.S.
Show Links |
|
|
|
|
|
|
Age 6 through 11 years (primary series) |
|
|
|
|
|
|
|
|
|
|
Age 18+ years (booster dose) |
|
|
|
|
|
|
Fact Sheets for Moderna COVID-19 Vaccines
 Age 12+ for primary series and age 18+ for 0.25 mL booster dose
(red cap, light blue border)
Show Links |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Emergency Use Instructions (EUI) |
|
|
|
|
|
|
Fact Sheets for Janssen (Johnson & Johnson) COVID-19 Vaccine
Show Links |
|
|
|
|
|
|
|
|
|
|
|
|
|
COVID-19 Vaccine Emergency Use Instructions (EUI) Resources (CDC)
Show Links |
|
|
|
|
|
|
|
| Clinic Resources and Tools |
|
|
|
|
|
| General vaccine administration information |
|
|
|
|
|
|
|
|
|
|
Prevaccination Checklist for COVID-19 Vaccines (CDC) [pdf] |
|
|
|
Translations:
Arabic,
Dari,
French (Canada),
Haitian Creole,
Korean,
Pashto,
Portuguese (Portugal),
Simplified Chinese,
Spanish,
Ukranian,
Vietnamese
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Pfizer-BioNTech COVID-19 vaccine (mRNA)
All formulations |
|
|
|
|
|
|
|
|
|
|
| Pfizer-BioNTech COVID-19 vaccine (mRNA)
Age 6 months through 4 years |
|
|
|
|
|
|
|
|
|
|
|
|
| Pfizer-BioNTech COVID-19 vaccine (mRNA)
Age 5 through 11 years (orange cap) |
|
|
|
|
|
|
|
|
|
|
| Pfizer-BioNTech COVID-19 vaccine (mRNA)
Age 12 years and older – dilute before use (purple cap) |
|
|
|
|
|
|
|
|
|
|
| Pfizer-BioNTech COVID-19 vaccine (mRNA)
Age 12 years and older – do not dilute (gray cap) |
|
|
|
|
|
|
|
|
|
|
| Moderna COVID-19 vaccine (mRNA)
Age 6 months through 5 years (dark blue cap, magenta [pink] border) |
|
|
|
|
|
|
|
|
|
|
| Moderna COVID-19 vaccine (mRNA)
Age 6 through 11 years (dark blue cap, purple border) |
|
|
|
|
|
|
Vaccine Preparation and Administration Summary: Moderna (n/a) |
|
|
|
|
|
|
|
Moderna COVID-19 vaccine (mRNA)
Age 12+ for primary series and age 18+ for 0.25 mL booster dose
(red cap, light blue border) |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Janssen COVID-19 Vaccine (Johnson & Johnson) (viral vector) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical considerations for use of COVID-19 vaccines
Show Links |
|
|
|
|
|
|
|
|
|
COVID-19 Vaccines, Recommendations, and Schedules |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Safety |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Special Situations and Populations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appendices |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Severe Allergic Reactions |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vaccine storage and handling (includes temperature logs)
Show Links |
|
|
|
|
| General storage and handling information |
|
|
|
|
|
|
|
|
|
|
|
|
COVID-19 Vaccine Storage Temperature Logs |
|
|
 |
|
Ultra-Cold Freezer (Pfizer-BioNTech vaccine) |
|
|
|
|
|
|
|
|
|
|
Freezer (Pfizer-BioNTech purple cap vaccine) |
|
|
|
|
|
|
|
|
|
|
Freezer (Moderna vaccine) |
|
|
|
|
|
|
|
|
|
|
Refrigerator (Pfizer-BioNTech, Moderna, and Janssen vaccines) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Pfizer-BioNTech COVID-19 vaccine (mRNA)
All formulations |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Pfizer-BioNTech COVID-19 vaccine (mRNA)
Age 6 months through 4 years (maroon cap) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Pfizer-BioNTech COVID-19 vaccine (mRNA)
Age 5 through 11 years (orange cap) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Pfizer-BioNTech COVID-19 vaccine (mRNA)
Age 12 years and older – dilute before use (purple cap) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Pfizer-BioNTech COVID-19 vaccine (mRNA)
Age 12 years and older – do not dilute (gray cap) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Moderna COVID-19 vaccine (mRNA)
All formulations |
|
|
|
|
|
|
|
| Moderna COVID-19 vaccine (mRNA)
Age 6 months through 5 years (dark blue cap, magenta [pink] border) |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Moderna COVID-19 vaccine (mRNA)
Age 6 through 11 years (dark blue cap, purple border) |
|
|
|
|
|
|
|
|
|
Beyond-Use Date (BUD) Tracking Labels for Vaccine During Freezer or Refrigerator Storage: Moderna (n/a) |
|
|
Moderna COVID-19 vaccine (mRNA)
Age 12+ for primary series and age 18+ for 0.25 mL booster dose
(red cap, light blue border) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Janssen COVID-19 Vaccine (Johnson & Johnson) (viral vector) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vaccine Provider Information |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Considerations for Vaccination of Special Populations |
|
|
|
|
|
|
|
|
|
Reimbursement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ACIP Recommendations
Vaccine Information Statements 
